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Protein 4.1RDuring development inside red blood cells (RBCs), Plasmodium falciparummalaria parasites export proteins that
associate with the RBC membrane skeleton. These interactions cause profound changes to the biophysical prop-
erties of RBCs that underpin the often severe and fatal clinical manifestations of falciparummalaria. P. falciparum
erythrocyte membrane protein 1 (PfEMP1) is one such exported parasite protein that plays a major role in
malaria pathogenesis since its exposure on the parasitised RBC surfacemediates their adhesion to vascular endo-
thelium and placental syncytioblasts. En route to theRBCmembrane skeleton, PfEMP1 transiently associateswith
Maurer's clefts (MCs), parasite-derived membranous structures in the RBC cytoplasm. We have previously
shown that a resident MC protein, skeleton-binding protein 1 (SBP1), is essential for the placement of PfEMP1
onto the RBC surface and hypothesised that the function of SBP1 may be to target MCs to the RBC membrane.
Since this would require additional protein interactions, we set out to identify binding partners for SBP1. Using
a combination of approaches, we have deﬁned the region of SBP1 that binds speciﬁcally to deﬁned sub-
domains of two major components of the RBC membrane skeleton, protein 4.1R and spectrin. We show that
these interactions serve as one mechanism to anchor MCs to the RBC membrane skeleton, however, while
they appear to be necessary, they are not sufﬁcient for the translocation of PfEMP1 onto the RBC surface. The
N-terminal domain of SBP1 that resides within the lumen of MCs clearly plays an essential, but presently
unknown role in this process.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Although malaria mortality rates have fallen by more than 40% over
the last decade or so, this parasitic disease continues to exert signiﬁcant,
yet avoidable health, social and economic burdens on society, particu-
larly in resource-poor, low and middle income countries. Each year,
about 200 million people become infected with malaria parasites and
more than half a million (predominantly young children in Africa) die
as a result of their infection [1,2]; almost always due to Plasmodium
falciparum. The extreme virulence of this parasite, compared to other
species of Plasmodium that infect humans and its propensity to cause
severe, often fatal disease, is underpinned by its ability to make the
red blood cell (RBC) in which it resides abnormally adhesive for a61 3 9902 9222.
).number of other cell types including vascular endothelial cells, placental
syncytiotrophoblasts, platelets, and other infected or non-infected RBCs.
Consequently, RBCs infectedwithmature stages of P. falciparum cease to
circulate and accumulate in multiple organs including the brain and
placenta with subsequent severe pathological consequences (see [3–5]
for reviews).
The altered adhesive properties of parasitised RBCs (PRBCs) is
mediated by a family of high molecular weight, antigenically-diverse,
parasite-encoded proteins collectively called P. falciparum erythrocyte
protein 1 (PfEMP1) that are transcribed from the varmulti-gene family
and presented on the surface of RBCs infected with mature-stage para-
sites. Different variants of PfEMP1 can bind to a number of host recep-
tors, principally CD36 and intracellular adhesion molecule-1 (ICAM-1),
expressed on the surface of vascular endothelial cells, and chondroitin
sulphate A (CSA) in the placenta [3].
The ability of PfEMP1 to mediate adhesion is dependent on its
correct presentation on the PRBC surface [6–9]. We and others have
previously shown that a parasite-encoded protein, skeleton-binding
Fig. 1. Association of the C-terminal domain of SBP1 with the RBC membrane skeleton. A.
Schematic representation of SBP1. Repeat regions (light grey) and the trans-membrane
domain (TM) are indicated. B. Binding of the SBP1 C-terminal domain (SBP1-C) to the
RBC skeleton. RBCs resealed with recombinant SBP1-C appended to YFP (SBP1-C–YFP;
lane 1), RBCs resealed with YFP alone (YFP; lane 2), intact RBCs incubated with SBP1-C–
YFP then washed (lane 3) or untreated RBCs (lane 4) were solubilised in TX-100. The
TX-100 soluble and insoluble fractions were resolved by SDS-PAGE and immuno-blotted
using an anti-YFP antibody. C. IOV binding assay with EMP3F1a as a positive control and
EMP3F5 and MBP as negative controls.
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onto the RBC surface and consequently for adhesion of PRBCs to the
vascular endothelium [10,11]. SBP1 is a trans-membrane protein, located
in parasite-induced membranous structures within the PRBC cytoplasm
known as Maurer's clefts (MCs) [12,13]. The topology of SBP1 is such
that its entire N-terminal domain (SBP1-N; Fig. 1) is enclosed within in
the lumen of the MC while its relatively shorter C-terminal tail (SBP1-C;
Fig. 1) is exposed on the outside of the cleft, facing into the RBC cytosol
[14]. Interestingly, disruption of the gene encoding SBP1 in P. falciparum
appears to alter the cellular distribution ofMCs, such that in RBCs infected
with transgenic parasites lacking SBP1 expression, MCs are located
further from the RBC membrane skeleton than in RBCs infected with
wild-type parasites [10]. We therefore hypothesised that SBP1-C or
domains within it bind speciﬁcally to protein components of the RBC
membrane skeleton and mediate transfer of PfEMP1 from MCs onto the
PRBC surface. To test this hypothesis, we have used a combination ofmo-
lecular, cellular and biophysical approaches to identify the proteins (and
sub-domains within them) that partake in this pathophysiologically-
important interaction. Our studies provide a better understanding of
the function of the C-terminal domain of SBP1, its role in the association
MCswith the RBCmembrane skeleton and the placement of PfEMP1 onto
the surface of PRBCs.2. Materials and methods
2.1. Malaria parasites
P. falciparum (3D7)was cultured in vitro in Albumax II-supplemented
RPMI1640 as previously described [15] in either normal or protein 4.1R-
deﬁcient RBCs [16]. Cultures were selected for the expression of
membrane knobs once per week using gelatin [17]. Asynchronous or
synchronous parasite extracts were prepared by either Percoll gradient
puriﬁcation [18] or saponin lysis [19].2.2. Generation of transgenic SBP1–AMA1-C P. falciparum clones
RBCs infectedwith young, ring-stage 3D7 parasites were transfected
with approximately 150 μg of plasmid DNA as previously described
[20,21]. The transforming plasmid was generated in the pCC1 vector
[22] in order to generate a double crossover event replacing the en-
tire C-terminal domain of SBP1 (amino acids 239–338) with that of
the C-terminal domain of AMA1 (amino acids 566–622). Parasites
were cultured in the presence of 2.5 nM WR99210 (Sigma-Aldrich)
until parasites were observed (~6 weeks). Four clonal parasite
lines, derived from two independent transfection events, were
obtained by limiting dilution. DNA from 3D7 parasites and all trans-
genic parasite lines was puriﬁed using Nucleon BACC2 (GE Healthcare
Life Sciences).2.3. Expression and puriﬁcation of proteins
Native spectrin (α/β-dimer) or protein 4.1R was puriﬁed from nor-
mal human RBCs as previously described [23]. Various recombinant
GST-tagged sub-domains of spectrin and protein 4.1R were expressed
in E. coli and puriﬁed as previously described [24,25]. Recombinant pro-
teins for SBP1were expressed as either theN-terminal region consisting
of amino acids 1–215 (SBP1-N) or the C-terminal domain consisting of
amino acids 239–338 (SBP1-C). Recombinant proteins for 6xHIS-
yellow ﬂuorescent protein (YFP) and SBP1-C–YFP were expressed
from the pET24a vector (Novagen), SBP1-C–GST and SBP1-N–GST
were cloned from the pGEX-KG vector [26] and SBP1-C–MBP and
AMA1-C–MBP were expressed from the pMAL vector (New England
Biolabs). All Proteins were expressed in E. coli BL21 DE3 and puriﬁed
on TALON metal afﬁnity resin (Clontech Laboratories) or amylose
resin (for MPB-fusion proteins) (New England Biolabs) or glutathione
resin (for GST-fusion proteins) (GE Healthcare) according to the
manufacturer's instructions.2.4. SDS-PAGE and immunoblotting
All samples of parasite lysates were resolved by SDS-PAGE using
either 12% (w/v) or 8% (w/v) polyacrylamide gels and stained with
Coomassie blue or transferred to polyvinylidene ﬂuoride (PVDF)
membranes (NEN) for western blot analysis. Anti-rabbit and anti-mouse
immunoglobulins conjugated to horseradish peroxidise (Silenus) were
used as secondary detection antibodies.2.5. Resealed RBC interaction assay
To determine whether SBP1-C could bind directly to the RBC mem-
brane skeleton, either SBP1-C–YFP or YFP recombinant proteins were
resealed inside RBCs then solubilised using the non-ionic detergent
TX-100 as previously described [27]. As a control, SBP1-C–YFP was
also incubated with intact, normal human RBCs, washed, and then
solubilised in the same way.
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2.6.1. Plate-based interaction assays
Plate-based protein–protein interaction assays using both puriﬁed
proteins and inside-out vesicles (IOVs) were performed as previously
described [28]. Brieﬂy, IOVs (RBCs that have been ‘ﬂipped’ inside-out
by osmotic lysis to generate vesicles that possess a properly conformed
RBC membrane skeleton exposed to the external surface) or puriﬁed
spectrin were used to coat 96-well plates. After washing the coated
wells, recombinant SBP1 proteinswere then added and incubated over-
night at 4 °C. Wells were then washed three times and bound proteins
striped from the plates with SDS sample buffer. Samples were then
analysed by conventional dot-blotting on nitrocellulose membrane.
2.6.2. Quantiﬁcation of protein–protein interactions by surface plasmon
resonance
Awell-established surface plasmon resonance-based technique was
used to quantify protein–protein interactions using a BIAcore 3000
(BIAcore, Piscataway, NJ, USA). The 16 kDa domain of protein 4.1 or
the α4 repeat region of α-spectrin was covalently immobilised onto a
CM-5 sensor chip using amino coupling (BIAcore). A series of binding
assays were performed by passing increasing concentrations of SBP1-C
over the same regenerated chip surface multiple times. Binding reac-
tions were performed at pH 7.4 in HEPES-buffered saline (150 mM
NaCl, 20mMHEPES) containing 3mMEDTAand 0.05% (v/v) P20 surfac-
tant. The surface was regenerated using 0.05% SDS before each new
injection of SBP1. Resulting sensograms (response units versus time)
were analysed using BIAeval v3.0 software (BIAcore). Afﬁnity constants
were estimated by curve ﬁtting using a 1:1 binding model.
2.6.3. Protein pull-down assays
To assess binding of spectrin or protein 4.1R to recombinant SPB1
fragments, GST-tagged SPB1-C was coupled to glutathione beads at
room temperature for 30 min. Beads were pelleted by centrifugation
and then washed. Spectrin (1 μM) or protein 4.1R (1 μM) was added
to the GST–SPB1-conjugated beads in a total volume of 100 μl. The
mixture was incubated at room temperature for 1 h. The pellet was
analysed by SDS-PAGE, transferred to nitrocellulose then probed with
anti-spectrin or anti-protein 4.1R-speciﬁc antibodies. The reverse was
also tested using GST-tagged spectrin or protein 4.1R fragments as the
bait and His-tagged SPB1 as the prey and the interaction detected
using anti-His-speciﬁc antibodies.
2.6.4. ELISA-based protein interaction inhibition assays
To examine the inhibition of SPB1–protein 4.1R interactions by the
16 kDa domain of protein 4.1R, puriﬁed, native protein 4.1R (200 ng
in 100 μl) was coated onto 96-well plates overnight at 4 °C. Plates
were then washed and blocked with 1% BSA in PBS containing 0.05%
tween-20 for 1 h at room temperature. His-tagged SPB1 (pre-incubated
with increasing concentrations of 16 kDa 4.1R) was added to protein
4.1R-coated plates and incubated for 30 min. Plates were then washed
and SPB1 binding to protein 4.1R was detected using anti-His
antibody/HRP-conjugated anti-rabbit IgG. The colour was developed
by adding TMB microwell peroxidase substrate and plates were read
in an ELISA plate reader at 450 nm. Similar experiments were
performed to examine the effect of the α4 repeat region of α-spectrin
on SPB1–spectrin interactions using, in this case, native, spectrin
dimer puriﬁed from normal human RBCs to coat 96-well plates.
2.7. Quantitative immunoﬂuorescence assays
RBCs from parasite cultures were smeared onto glass slides and
ﬁxed in 9:1 acetone/methanol for 10 min on ice before being used for
quantitative immunoﬂuorescence assays. Primary antibodies were
either polyclonal mouse anti-spectrin (1:500), polyclonal rabbit anti-
glycophorin A (1:2000) or polyclonal rabbit anti-SBP1 (1:500). AlexaFluor 488- or Alexa Fluor 568-conjugated anti-rabbit or anti-mouse
immunoglobulin (1:3000; Molecular Probes Inc.) was used as second-
ary antibodies. Immuno-labelled smears were examined by wide-ﬁeld
or confocal ﬂuorescence microscopy and digital images captured for
analysis and quantitation using ImageJ [29]. To quantify co-localisation
of MCs (SBP1) with spectrin in RBCs infected with either normal
(3D7) or transgenic SBP1–AMA1-C parasites, ﬂuorescence images
from 10 individual, randomly selected PRBCs for each parasite line
were analysed and co-localisation quantiﬁed using the Manders' co-
localisation coefﬁcient [30].
2.8. PRBC adhesion assay
The adhesive properties of PRBCs were analysed and quantiﬁed
using an in vitro microslide ﬂow-based adhesion assay with mono-
layers of human, activated platelets (CD36) as the adhesive target
as previously described in detail [31,32]. Assays were performed on
highly synchronised parasite cultures in which the majority of
PRBCs contained mature, pigmented trophozoites with parasitaemia
ranging between 3 and 5%. In all cases, adhesion was quantiﬁed at a
physiologically-relevant wall shear stress of 0.1 Pa.
2.9. Analysis of surface PfEMP1 expression on PRBCs
Exposure of PfEMP1 on the surface of PRBCs was quantiﬁed using
the indirect trypsin cleavage assay exactly as previously described
[10]. In essence, PRBCs were puriﬁed using Percoll from synchronised
cultures following gelatin ﬂotation. After trypsin treatment of intact
PRBCs, membrane surface-exposed proteins (including PfEMP1) were
extracted in 1% Triton-X 100 followed by solubilisation in SDS. Samples
were then resolved using SDS-PAGE (6%) then transferred to PVDF
membrane for western blot analysis.
2.10. Scanning electron microscopy
RBCs from synchronised parasite cultures (mature trophozoites)
were prepared using standard methods, sputter-coated with gold, and
then examined using a Quanta 200 FEG Environmental Scanning
Electron Microscope. Sixty images of randomly selected PRBCs (30 for
each parasite line, 3D7 and SBP1–AMA1-C) were used to quantify the
number of knobs on the surface of PRBCs by counting the number of
knobs on a ﬂat, randomly-selected 1/μm2 area of PRBC membrane.
3. Results
3.1. The C-terminal domain of SBP1 (SBP1-C) binds to the RBC skeleton
We used multiple approaches to demonstrate that SBP1-C interacts
directly with the RBC membrane skeleton. Firstly, we introduced a
recombinant protein comprising only the C-terminal domain of SBP1
appended to YFP (SBP1-C–YFP) into intact, hypotonically-resealed
RBCs then subsequently solubilised a lysate of these cells in thepresence
of the non-ionic detergent Tx100. We showed that SBP1-C–YFP
partitioned exclusively into the Tx100-insoluble fraction. In contrast,
under identical experimental conditions, recombinant YFP alone was
found only in the Tx100 soluble fraction (Fig. 1B). Secondly, we con-
ﬁrmed that this interaction of SBP1-C with the RBCmembrane skeleton
was speciﬁcally with components of the membrane skeleton itself and
not with other components of the membrane since neither SBP1-C–
YFP nor YFP showed any detectable interaction with the RBC when
these proteins were incubated with intact, normal human RBCs
(Fig. 1B). Together, these data indicate that SBP1-C interacts speciﬁcally
with the RBCmembrane skeleton that lines the inner (cytoplasmic) face
of the RBC. Thirdly, we used an in vitroplate-based assay to demonstrate
a direct binding interaction between SBP1-C and immobilised vesicles
of RBCs that had been ﬂipped inside-out (IOVs) to expose the
Fig. 2. Binding of SBP1 C-terminal domain to protein 4.1R. A. GST-tagged or N- or C-terminal
SBP1was used to pull down 4.1R puriﬁed fromRBCs. Bindingwas detected by immunoblot-
ting using speciﬁc anti-4.1R antibodies. This result is a representative example of 3 indepen-
dent binding experiments all of which showed identical results. B. Schematic representation
of protein 4.1R, showing the deﬁned structural regions that were expressed as recombinant
fragments as previously described [25]. The Coomassie-stained gel shows the puriﬁed re-
combinant proteins. C. Binding of the SBP1 C-terminal domain to protein 4.1R domains.
GST-tagged 4.1R domains (expressed in pGEX-4T-2) were used to pull down His-tagged
SBP1 C-term (expressed in pET24a). SBP1 binding was detected by immuno-blotting using
an anti-hexahistidine antibody. D. Inhibition of binding of SBP1 C-terminal domain to
protein 4.1R by the 16 kDa domain of protein 4.1. His-tagged SBP1-C was pre-incubated
with increasing concentrations of either GST-tagged 16 kDa protein 4.1 domain or GST-
tagged 22/24 kDa domain at room temperature for 30 min. Mixtures were then added to a
96-well plate that had been coated with 4.1R. The binding of His-tagged SBP1 C-term was
detected using an anti-His antibody. Note the progressive decrease of SBP1-C binding to pro-
tein 4.1R with the increasing concentrations of 16 kDa but not with 22/24 kDa domains of
protein 4.1. Data are the mean ± S.E.M. from three separate experiments.
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resealing experiments, a recombinant fusion protein comprising SBP1-C
fused to maltose-binding protein (SBP1-C–MBP) bound to IOVs where-
as MBP alone showed no detectable binding under identical conditions.
A fragment of a previously characterised RBC membrane-interacting
malaria protein, PfEMP3 [28] was used as a positive binding control in
these experiments and bound as expected to IOVs (Fig. 1C). Thus, in
three different assays, SBP1-C displayed properties characteristic of a
RBC membrane skeleton binding protein. Importantly, we ruled out
the possibility that this interaction with the RBC membrane skeleton
was a universal feature of the C-terminal domains of P. falciparum
proteins by demonstrating that a recombinant MBP-fusion protein
comprising the C-terminal domain of apical merozoite antigen 1
(AMA1) [33] (similar in length to SBP1-C but unrelated in sequence)
failed to interact with IOVs under identical conditions (Fig. 1C).
3.2. SBP1-C binds to spectrin and protein 4.1
We next sought to identify the speciﬁc component(s) of the RBC
membrane skeleton with which SBP1-C interacts. Given that we have
previously described in detail the interactions of numerous exported
malaria proteins with protein 4.1 and/or spectrin [34] we purposely se-
lected these proteins as initial potential targets. Using either protein 4.1
or spectrin that had been puriﬁed from human RBCs and GST-tagged
recombinant versions of both SBP1-C and the entire N-terminal domain
of SBP1 (SBP1-N) in multiple protein pull-down experiments, SBP1-C
but not SBP1-N nor GST alone was able to consistently pull-down both
protein 4.1 (Fig. 2A) and spectrin (Fig. 3A). Further, identical pull-
down assays using multiple non-overlapping sub-fragments of either
protein 4.1 (Fig. 2B) orα-spectrin (Fig. 3B) revealed that the interaction
of SBP1-C with protein 4.1 was conﬁned predominantly to the 16 kDa
fragment of protein 4.1, although there was also a weak interaction
with the 10 kDa fragment (Fig. 2C). For spectrin, binding was conﬁned
exclusively to within the ﬁrst ﬁve N-terminal repeats of α-spectrin
(αN1-5) (Fig. 3B), speciﬁcally to the α4 repeat (Fig. 3C).
To further conﬁrm the speciﬁcity of these interactions, we used the
16 kDa fragment of protein 4.1 and the α4 repeat region of α-spectrin
in a competitive binding assay (Figs. 2D and 3D). In the presence of
increasing concentrations of either the 16 kDa fragment of protein 4.1
or the α4 repeat region of α-spectrin, the binding of SBP1-C to either
native protein 4.1 or spectrin respectively was progressively inhibited
in a concentration-dependent manner.
3.3. Kinetic analysis of the interaction between SBP1-C, protein 4.1 and
spectrin
We used surface plasmon resonance to quantify the interaction
between SBP1-C and protein 4.1 or spectrin. Analysis of quantitative
binding data, obtained from four separate experiments, revealed that
SBP1-C bound to the 16 kDa fragment of protein 4.1 or the α4 repeat
region of α-spectrin with very high afﬁnity (KD ≈ 0.06 μM and
0.02 μM respectively; Table 1). These dissociation constants reﬂect
higher afﬁnity interactions than are commonly seen formalaria proteins
at the RBC skeleton but are not unprecedented [3].
3.4. Protein 4.1R is necessary for efﬁcient localisation of Maurer's clefts at
the RBC membrane skeleton
To determine whether the interaction between SBP1-C and the RBC
membrane skeleton was of functional relevance in vivo, we determined
and quantiﬁed, by IFA and confocal microscopy, the localisation of MCs
in parasite-infected human RBC that were genetically deﬁcient in
protein 4.1R. Notably, while the appearance and number of MCs by
IFA was similar in both normal and 4.1R-deﬁcient infected RBCs, the
proportion of MCs that were located at the RBC membrane skeleton
(as measured by the co-localisation of SBP1 with the integral RBCmembrane-skeleton protein, glycophorin A) was signiﬁcantly lower
(P b 0.0001; Mann–Whitney U test) in 4.1R-deﬁcient RBCs (mean co-
localisation= 62.8± 2.4%; n= 73 versus 42.2± 1.9%; n= 102 for nor-
mal and 4.1R-deﬁcient RBCs respectively) (Fig. 4). This data strongly
supports that the interaction between SBP1-C and protein 4.1R plays a
signiﬁcant role in localising MCs to their ﬁnal destination in the PRBC,
tethered to the RBC membrane skeleton [35].
Fig. 3. Binding of SBP1 C-terminal domain to spectrin. A. GST-tagged or N- or C-terminal
SBP1was used to pull down full-length spectrin puriﬁed from RBCs. Binding was detected
by immunoblotting using speciﬁc anti-spectrin antibodies. A representative example of 3
independent binding experiments is shown but all 3 experiments showed essentially
identical results. B. Schematic representation of the spectrin α- and β-chains; regions
expressed as recombinant fragments are indicated [24].Western blot showing the binding
of SBP1-C to spectrin fragments, speciﬁcally theα-N5 repeats. C.α-N5 repeats were divid-
ed into the individual repeats expressed as GST fusion proteins and used to pull down the
hexahistidine-tagged SBP1 C. Binding was detected by western blotting using anti-
hexahistidine antibody. GSTwas used as negative control in all experiments. SBP1 binding
was detected by immuno-blotting with an anti-hexahistidine antibody. D. Inhibition of
binding of SBP1-C to the α4 repeat region of α-spectrin. Competitive inhibition was
measured by an enzyme-linked immunosorbent assay (ELISA). SBP1-C was coated on
96-well plates then pre-incubated with various concentrations of the α4 repeat region
of α-spectrin prior to the addition of puriﬁed spectrin dimer. The binding of spectrin
dimer to SBP1-C decreased with progressively increasing concentrations of the α4 repeat
region of α-spectrin. Data are the mean ± S.E.M. from three separate experiments.
Table 1
SBP1-C terminal domain interactions with proteins of the RBC skeleton. Protein–protein
interactionswere performed using a BIAcore 3000 (BIAcore, Piscataway, NJ, USA). Binding
experiments (n= 4 for either protein fragment interacting with SBP1-C)were performed
at pH 7.4 in HEPES-buffered saline (150 mMNaCl, 20mMHEPES) containing 3 mM EDTA
and 0.05% (v/v) P20 surfactant. Afﬁnity constants were estimated by curve ﬁtting using
BIAeval v3.0 software assuming a 1:1 binding model.
SBP1-C ka
(×104 m−1 s−1)
kd
(×10−4 s−1)
KA
(×107 M−1)
KD
(×10−8 M)
4.1 (16 kDa) 0.80 ± 0.55 4.59 ± 0.05 1.73 ± 0.11 5.85 ± 0.46
α-spectrin (α4) 1.61 ± 0.13 3.10 ± 0.42 5.70 ± 1.28 2.04 ± 0.42
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PRBCs
Based on this data we reasoned that deletion of SBP1-C would affect
the localisation ofMCs in PRBCs and prevent their close associationwith
the RBC membrane skeleton. Despite multiple attempts, we were
unable to derive a transgenic parasite line in which the entire SBP1-C
region was deleted from the endogenous sbp1 gene. We therefore
derived 3 independent clonal lines of transgenic parasites all stablyexpressing a chimeric full-length SBP1 protein in which the SBP1-C
domain had been replaced with a C-terminal domain of similar length
from apical membrane antigen 1 (AMA1-C) (Fig. 5), a completely unre-
lated malaria protein. As previously stated above, when tested in vitro,
recombinant AMA1-C showed no interaction with IOVs (Fig. 1). When
analysed by IFA, parasite clones expressing chimeric SBP1 comprising
the N-terminal domain of SBP1 and the C-terminal domain of AMA1
(SBP1–AMA1-C) localised this protein correctly to MCs (Fig. 5B). To
our surprise however, when MCs were co-localised with spectrin
(Fig. 6A) (as a measure of their association with the RBC membrane
skeleton), their distribution in PRBCs was not signiﬁcantly different to
that found in wild type, parental 3D7 parasites (Fig. 6A).
Furthermore, examination by scanning electron microscopy of 30
randomly selected RBCs infected with either 3D7 or SBP1–AMA1-C par-
asites revealed that SBP1–AMA1-C parasites formed normal membrane
knobs on the PRBC surface, both morphologically (Fig. 6C) and numeri-
cally (8.72 ± 0.49 knobs/μm2 for 3D7 versus 8.91 ± 0.50 knobs/μm2
for SBP1–AMA1-C; mean ± SEM), trafﬁcked PfEMP1 normally to the
RBC surface as assessed by trypsin-cleavage analysis (Fig. 6E) and
their ability to adhere to platelet-expressed CD36 under ﬂow conditions
were not signiﬁcantly different to RBCs infected with wild-type 3D7
parasites (Fig. 6D). Taken together, these results indicate that the
C-terminal domain of SBP1 is not required for either correct localisation
of MCs at the RBC membrane skeleton, the formation of parasite-
induced knobs at the RBC membrane or the delivery to and function
of PfEMP1 on the PRBC surface.
4. Discussion
Correct trafﬁcking and display of PfEMP1 on the surface of PRBCs is
critical for the extreme virulence of P. falciparummalaria parasites and
plays a central role in the pathogenesis of falciparum malaria. We and
others have previously shown that the correct placement of PfEMP1
on the PRBC surface, clustered over membrane knobs, is dependent on
the presence of SBP1, a protein resident in MCs in the cytoplasm of
PRBCs [10,11]. However, the precise mechanism bywhich translocation
of PfEMP1 onto the RBC surface occurs has, to the best of our knowledge,
never been determined. Analysis of MCs during the intra-erythrocytic
development of P. falciparum has shown that they are initially highly
mobile structures during the early stages of parasite infection, but be-
come stationary and immobilised at the RBC membrane as the parasite
matures into pigmented trophozoites [36]. Furthermore, they appear to
become anchored directly to the RBC skeleton, via an interaction involv-
ing either membrane tethers [35,37], novel actin ﬁlaments [38,39] or,
most likely, a combination of the two. Since, to us, it seemed highly
likely that this anchoring of MCs to the RBC membrane skeleton would
be a critical requirement for the translocation of PfEMP1 onto the PRBC
surface, and that the C-terminal domain of SBP1 is exposed on the surface
of MCs, we set out to identify proteins of the RBC membrane skeleton
with which the C-terminal domain of SBP1 could interact and whether
these interactions were necessary for surface exposure of PfEMP1.
Here, we have been able to show by a number of different ap-
proaches that SBP1-C is able to speciﬁcally bind to the RBC cytoskeleton
via both the 16 kDa domain of protein 4.1R and the α4 repeat region of
Fig. 4. Localisation of SBP-1 in normal and protein 4.1R-deﬁcient red blood cells. Representative confocal immunoﬂuorescence images of normal (A) and 4.1R-deﬁcient (C) RBCs immuno-
labelled forMaurer's clefts (SBP1; green) and the RBCmembrane skeleton (Glycophorin A, GpA; red). Co-localisation of SBP1 and GpAwas analysed using ImageJ and the fraction of MCs
(SBP1) co-localised with the RBCmembrane skeleton in 73 normal (B) and 102 protein 4.1R-deﬁcient (D) RBCs plotted. A signiﬁcant shift in themean co-localisation of SBP1with GpA is
observed between normal and 4.1R-deﬁcient RBCs.
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sufﬁcient magnitude (KD ~ 0.02–0.06 μM) to be capable of playing a
physiological role in vivo [3]. Furthermore, the number of MCs associat-
ingwith themembrane skeleton inmutant humanRBC that lack protein
4.1R, was considerably reduced, suggesting that binding to protein 4.1R
by SBP1 likely plays a signiﬁcant role in MC localisation. To date, a
number of exported malaria proteins have been shown to interact di-
rectly with the RBC membrane skeleton, including at least 3 (KAHRP,
PfEMP3 and RESA) that interact speciﬁcally with distinct domainswith-
in spectrin, and one (MESA) with protein 4.1R [34]. Considering that
both KAHRP and PfEMP3, in addition to SBP1, are required for the
correct trafﬁcking and display of functional PfEMP1 on the surface of
PRBCs [6,10,11,40], this strengthens the importance of the α4 repeat
region of spectrin as playing a highly signiﬁcant role in PfEMP1 trafﬁck-
ing and PRBC surface display.
To further determine the role of SBP1-C in vivo, we attempted to
truncate the endogenous SBP1 protein in parasites, but despitemultiple
attempts, we were unable to generate transgenic parasites lacking only
the C-terminal domain of SBP1. This, however, is not unprecedented asthe inability to delete short, cytoplasmic C-terminal domains (C-terminal
tails) that follow the transmembrane domain from a number of other
eukaryotic proteins without altering the normal trafﬁcking of the whole
protein [41,42], including those from P. falciparum [43] has been
described. Since we could not speciﬁcally delete SBP1-C, we decided to
replace it with a C-terminal domain of similar length from an unrelated
malaria protein. We selected the cytoplasmic tail of apical membrane
antigen 1 (AMA1-C) since it has no sequence similarity to SBP1-C, nor a
previously described function in protein–protein interactions, and its
timing of expression and localisation in PRBCs are different from that of
SBP1-C [33,44–46]. This SBP1-N–AMA1-C chimeric protein localised to
MCs as expected, but interestingly, MCs showed no signiﬁcant difference
in their association with the PRBC membrane skeleton when compared
to RBCs infected with wild type parental parasites. This indicated to us
that although SBP1-C is capable of interacting with the RBC membrane
skeleton, it is not essential for the interaction of MCs with themembrane
skeleton in PRBCs. It is therefore possible that this interaction with the
RBC cytoskeleton is a redundant function which could be performed by
one or other proteins that are resident in MCs and exposed on the
Fig. 5. Localisation of SBP1 C-terminal mutants. A. Southern blot analysis of the SBP1–AMA1-C parasite clones. The left panel is a schematic representation of the expected integration
event. The restriction enzymes and the size of the expected bands are indicated. The right panel is the southern blot probed with an SBP1 gene-speciﬁc probe. The corresponding
bands from thewild type (3D7), transfected plasmid, and integration events in the SBP1–AMA1-C clones (1C9, 1D7 and 1G3) are shown. B. Immunoﬂuorescence analysis of RBCs infected
with either normal (3D7) or transgenic parasites expressing a chimeric SBP1 protein in which the C-terminal domain of SBP1 was replaced with the C-terminal domain of P. falciparum
AMA1 (SBP1–AMA1-C).
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been described is REX1 [47]. This is also supported by observations that
MCs are attached to the RBC cytoskeleton by membranous tethers that
appear to emanate from MCs, but which do not contain SBP1 [35,48].
Additionally, more recent ﬁndings suggest that a novel form of actin ﬁla-
mentsmay also be involved in immobilisingMCs, however sinceMCs canbecome stationary in the presence of cytochalasin D, which disrupts actin
ﬁlaments [37] this implies that there are likely to be multiple mecha-
nisms mediating this process in PRBCs. This premise of multiple mecha-
nisms is supported by our ﬁndings that in 4.1R-deﬁcient RBCs, MCs
were no longer as close to the RBC membrane skeleton as they were in
parasitised normal RBCs.
Fig. 6. Functional analysis of the SBP1 C-terminal domain. A. Representative images from immunoﬂuorescence analysis RBCs infected with wild type 3D7 parasites or the three clonal
parasite lines for the SBP1–AMA1-C chimeras (1C9, 1D7 and 1G3). Green represents SBP1 and red is spectrin. B. Scatter plot of the co-localisation analysis. Each data point represents
the Manders' coefﬁcient calculated from multiple individual images. The horizontal line represents the mean and the error bars are the SEM. C. Representative scanning electron micro-
graphs of RBCs infectedwith wild type 3D7 (top panel) or SBP1–AMA1-C (bottom panel) parasites showing the similarity in knob number andmorphology between the parasite lines. D.
The level of adhesion of PRBCs to platelet-expressed CD36 underﬂow conditions (0.1 Pa). Adherent PRBCs represent the number of 3D7- or SBP1–AMA1-C- (1C9, 1D7 and 1G3) PRBCs that
adhered per 107 PRBCs perfused through platelet-coated ﬂow chambers. Data represent the mean + SEM for 3 independent experiments. E. Trypsin cleavage assay to determine the
surface exposure of PfEMP1 in RBCs infected with SBP1–AMA1-C clonal parasite lines. The cleavage product at 75 kDa detected by anti-VARC (PfEMP1) antibody in wild type 3D7 and
all SBP1–AMA1-C clones indicate that trafﬁcking and surface exposure of PfEMP1 is similar for all parasite lines. Trypsin-mediated cleavage of glycophorin A (GpA)was used as a positive
control for trypsin cleavage activity.
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MCs to the PRBC membrane is intriguing, the difﬁculty in obtaining
large enough quantities of these relatively rare RBCs to perform detailed
mechanistic experiments is not currently feasible, so for the time being
at least, the precise functional consequences of the interaction between
SBP1-C and protein 4.1R remain unknown. Earlier published studies
from our laboratory however have demonstrated that the adhesion of
parasite-infected protein 4.1R-deﬁcient RBCs to C32 melanoma cells
is not different to parasite-infected normal RBCs suggesting thattrafﬁcking and transport of PfEMP1 and knob-formation in protein
4.1R-deﬁcient RBCs is the same as in normal RBCs [16]. To determine
whether the C-terminal tail of SBP1 was required for the trafﬁcking or
surface display of PfEMP1, we looked for changes in both the adhesive
properties of the PRBC and the surface localisation of PfEMP1 on the
SBP1–AMA1-C chimeric parasite lines. In all 3 clones, there was no dif-
ference in the trafﬁcking of PfEMP1 or the ability of the PRBC to adhere.
This indicated that while SBP1 was able to bind to the membrane
skeleton, this binding was not critical for either the localisation of MCs
1627L.M. Kats et al. / Biochimica et Biophysica Acta 1848 (2015) 1619–1628or for the overall function of SBP1 in the trafﬁcking and translocation of
PfEMP1. This seems to be completely discrepant with the known func-
tion of SBP1. In previous studies, by us and others, it was clear that
SBP1 is critical for the trafﬁcking of PfEMP1 to the surface of the PRBC
[10,11]. It was therefore reasonable to expect that SBP1-C, which is
exposed on the cytoplasmic face of MCs and binds the membrane
skeleton, would be involved in the trafﬁcking of PfEMP1. However,
our ﬁnding thatMCs are able to localise to the RBCmembrane in the ab-
sence of SBP1-C and the lack of any obvious PfEMP1 trafﬁcking defects,
suggests that the important function of SBP1 is not in the C-terminus
but lies within the N-terminal domain of the protein. Further character-
isation of this region of SBP1 and determination of its role in PfEMP1
trafﬁcking and transport is undoubtedly an important area for future
studies of malaria pathogenesis.
Transparency document
The Transparency document associated with this article can be
found, in the online version.
Acknowledgements
This work was supported by grants from the National Health and
Medical Research Council of Australia (NHMRC) (Project Grant 606447
to BMC and Fellowships 545831 to BMC and 606734 to LMK) and by
the National Institutes of Health (DK 26263 and DK 32094 and DK
100810).We thank the Australian Red Cross Blood Service for generous-
ly providing human red blood cells for in vitromalaria culture.
References
[1] P.W. Gething, A.P. Patil, D.L. Smith, C.A. Guerra, I.R. Elyazar, G.L. Johnston, A.J. Tatem,
S.I. Hay, A new world malaria map: Plasmodium falciparum endemicity in 2010,
Malar. J. 10 (2011) 378.
[2] C.J. Murray, L.C. Rosenfeld, S.S. Lim, K.G. Andrews, K.J. Foreman, D. Haring, N.
Fullman, M. Naghavi, R. Lozano, A.D. Lopez, Global malaria mortality between
1980 and 2010: a systematic analysis, Lancet 379 (2012) 413–431.
[3] B.M. Cooke, N. Mohandas, R.L. Coppel, Themalaria-infected red blood cell: structural
and functional changes, Adv. Parasitol. 50 (2001) 1–86.
[4] B.M. Cooke, N. Mohandas, R.L. Coppel, Malaria and the red blood cell membrane,
Semin. Hematol. 41 (2004) 173–188.
[5] A.G.Maier, B.M. Cooke, A.F. Cowman, L. Tilley,Malaria parasite proteins that remodel
the host erythrocyte, Nat. Rev. Microbiol. 7 (2009) 341–354.
[6] B.S. Crabb, B.M. Cooke, J.C. Reeder, R.F. Waller, S.R. Caruana, K.M. Davern, M.E.
Wickham, G.V. Brown, R.L. Coppel, A.F. Cowman, Targeted gene disruption shows
that knobs enable malaria-infected red cells to cytoadhere under physiological
shear stress, Cell 89 (1997) 287–296.
[7] L.M. Kats, K.M. Fernandez, F.K. Glenister, S. Herrmann, D.W. Buckingham, G.
Siddiqui, L. Sharma, R. Bamert, I. Lucet, M. Guillotte, O. Mercereau-Puijalon, B.M.
Cooke, An exported kinase (FIKK4.2) that mediates virulence associated-changes
in Plasmodium falciparum-infected red blood cells, Int. J. Parasitol. 44 (2014)
319–328.
[8] N.I. Proellocks, S. Herrmann, D.W. Buckingham, E. Hanssen, E.K. Hodges, B. Elsworth,
B.J. Morahan, R.L. Coppel, B.M. Cooke, A lysine-rich membrane-associated PHISTb
protein involved in alteration of the cytoadhesive properties of Plasmodium
falciparum-infected red blood cells, FASEB J. 28 (2014) 3103–3113.
[9] R.M. Fairhurst, C.D. Bess, M.A. Krause, Abnormal PfEMP1/knob display on Plasmodium
falciparum-infected erythrocytes containing hemoglobin variants: fresh insights into
malaria pathogenesis and protection, Microbes Infect. 14 (2012) 851–862.
[10] B.M. Cooke, D.W. Buckingham, F.K. Glenister, K.M. Fernandez, L.H. Bannister, M.
Marti, N. Mohandas, R.L. Coppel, A Maurer's cleft-associated protein is essential
for expression of the major malaria virulence antigen on the surface of infected
red blood cells, J. Cell Biol. 172 (2006) 899–908.
[11] A.G. Maier, M. Rug, M.T. O'Neill, J.G. Beeson, M. Marti, J. Reeder, A.F. Cowman,
Skeleton-binding protein 1 functions at the parasitophorous vacuole membrane to
trafﬁc PfEMP1 to the Plasmodium falciparum-infected erythrocyte surface, Blood
109 (2007) 1289–1297.
[12] T. Blisnick, M.E. Morales Betoulle, J.C. Barale, P. Uzureau, L. Berry, S. Desroses, H.
Fujioka, D. Mattei, C. Braun Breton, Pfsbp1, a Maurer's cleft Plasmodium falciparum
protein, is associated with the erythrocyte skeleton, Mol. Biochem. Parasitol. 111
(2000) 107–121.
[13] E. Mundwiler-Pachlatko, H.P. Beck, Maurer's clefts, the enigma of Plasmodium
falciparum, Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 19987–19994.
[14] T. Saridaki, K.S. Frohlich, C. Braun-Breton,M. Lanzer, Export of PfSBP1 to the Plasmodium
falciparumMaurer's clefts, Trafﬁc 10 (2009) 137–152.[15] S.L. Cranmer, C. Magowan, J. Liang, R.L. Coppel, B.M. Cooke, An alternative to serum
for cultivation of Plasmodium falciparum in vitro, Trans. R. Soc. Trop. Med. Hyg. 91
(1997) 363–365.
[16] C. Magowan, R.L. Coppel, A.O. Lau, M.M. Moronne, G. Tchernia, N. Mohandas,
Role of the Plasmodium falciparummature-parasite-infected erythrocyte surface
antigen (MESA/PfEMP-2) in malarial infection of erythrocytes, Blood 86 (1995)
3196–3204.
[17] J.G.Waterkeyn, A.F. Cowman, B.M. Cooke, Plasmodium falciparum: gelatin enrichment
selects for parasites with full-length chromosome 2. Implications for cytoadhesion
assays, Exp. Parasitol. 97 (2001) 115–118.
[18] A.R. Dluzewski, I.T. Ling, K. Rangachari, P.A. Bates, R.J.M.Wilson, A simplemethod for
isolating viable mature parasites of Plasmodium falciparum from cultures, Trans. R.
Soc. Trop. Med. Hyg. 78 (1984) 622–624.
[19] S.R. Christopher, J.D. Fulton, Experimentswith isolatedmalaria parasites (Plasmodium
knowlesi) free from red cells, Ann. Trop. Med. Parasitol. 33 (1939) 161–170.
[20] Y. Wu, L.A. Kirkman, T.E. Wellems, Transformation of Plasmodium falciparummalaria
parasites by homologous integration of plasmids that confer resistance to pyrimeth-
amine, Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1130–1134.
[21] D.A. Fidock, T.E. Wellems, Transformation with human dihydrofolate reductase
renders malaria parasites insensitive to WR99210 but does not affect the intrinsic
activity of proguanil, Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10931–10936.
[22] A. Maier, J. Braks, A. Waters, A. Cowman, Negative selection using yeast cytosine
deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted
gene deletion by double crossover recombination, Mol. Biochem. Parasitol. 150
(2006) 118–121.
[23] J.M. Tyler, W.R. Hargreaves, D. Branton, Puriﬁcation of two spectrin-binding proteins:
biochemical and electronmicroscopic evidence for site-speciﬁc reassociation between
spectrin and bands 2.1 and 4.1, Proc. Natl. Acad. Sci. U. S. A. 76 (1979) 5192–5196.
[24] X. Pei, X. Guo, R. Coppel, N. Mohandas, X. An, Plasmodium falciparum erythrocyte
membrane protein 3 (PfEMP3) destabilizes erythrocyte membrane skeleton, J.
Biol. Chem. 282 (2007) 26754–26758.
[25] K.L. Waller, W. Nunomura, X. An, B.M. Cooke, N. Mohandas, R.L. Coppel, Mature
parasite-infected erythrocyte surface antigen (MESA) of Plasmodium falciparum
binds to the 30-kDa domain of protein 4.1 in malaria-infected red blood cells,
Blood 102 (2003) 1911–1914.
[26] K.L. Guan, J.E. Dixon, Eukaryotic proteins expressed in Escherichia coli: an improved
thrombin cleavage and puriﬁcation procedure of fusion proteins with glutathione
S-transferase, Anal. Biochem. 192 (1991) 262–267.
[27] H. Weng, X. Guo, J. Papoin, J. Wang, R. Coppel, N. Mohandas, X. An, Interaction
of Plasmodium falciparum knob-associated histidine-rich protein (KAHRP) with
erythrocyte ankyrin R is required for its attachment to the erythrocyte membrane,
Biochim. Biophys. Acta 1838 (2014) 185–192.
[28] K.L. Waller, L.M. Stubberﬁeld, V. Dubljevic, W. Nunomura, X. An, A.J. Mason, N.
Mohandas, B.M. Cooke, R.L. Coppel, Interactions of Plasmodium falciparum erythro-
cyte membrane protein 3 with the red blood cell membrane skeleton, Biochim.
Biophys. Acta 1768 (2007) 2145–2156.
[29] T.J. Collins, ImageJ for microscopy, BioTechniques 43 (2007) S25–S30.
[30] E.M.M. Manders, F.J. Verbeek, J.A. Aten, Measurement of co-localisation of objects in
dual-colour confocal images, J. Microsc. 169 (1993) 375–382.
[31] B.M. Cooke, R.L. Coppel, G.B. Nash, Analysis of the adhesive properties of Plasmodium
falciparum-infected red blood cells under conditions of ﬂow, Methods Mol. Med. 72
(2002) 561–569.
[32] B.M. Cooke, R.L. Coppel, G.B. Nash, Preparation of adhesive targets for ﬂow-based
cytoadhesion assays, Methods Mol. Med. 72 (2002) 571–579.
[33] K. Leykauf, M. Treeck, P.R. Gilson, T. Nebl, T. Braulke, A.F. Cowman, T.W. Gilberger,
B.S. Crabb, Protein kinase a dependent phosphorylation of apical membrane antigen
1 plays an important role in erythrocyte invasion by the malaria parasite, PLoS
Pathog. 6 (2010) (e1000941).
[34] B.M. Cooke, J. Stuart, G.B. Nash, The cellular and molecular rheology of malaria,
Biorheology 51 (2014) 99–119.
[35] E. Hanssen, P. Carlton, S. Deed, N. Klonis, J. Sedat, J. DeRisi, L. Tilley, Whole cell
imaging reveals novel modular features of the exomembrane system of the malaria
parasite, Plasmodium falciparum, Int. J. Parasitol. 40 (2010) 123–134.
[36] C. Spycher, M. Rug, N. Klonis, D.J. Ferguson, A.F. Cowman, H.P. Beck, L. Tilley, Genesis
of and trafﬁcking to the Maurer's clefts of Plasmodium falciparum-infected erythro-
cytes, Mol. Cell. Biol. 26 (2006) 4074–4085.
[37] P.J. McMillan, C. Millet, S. Batinovic, M. Maiorca, E. Hanssen, S. Kenny, R.A. Muhle, M.
Melcher, D.A. Fidock, J.D. Smith, M.W. Dixon, L. Tilley, Spatial and temporal mapping
of the PfEMP1 export pathway in Plasmodium falciparum, Cell. Microbiol. 15 (2013)
1401–1418.
[38] M. Cyrklaff, C.P. Sanchez, F. Frischknecht, M. Lanzer, Host actin remodeling and
protection frommalaria by hemoglobinopathies, Trends Parasitol. 28 (2012) 479–485.
[39] M. Cyrklaff, C.P. Sanchez, N. Kilian, C. Bisseye, J. Simpore, F. Frischknecht, M. Lanzer,
Hemoglobins S and C interfere with actin remodeling in Plasmodium falciparum-
infected erythrocytes, Science 334 (2011) 1283–1286.
[40] J.G. Waterkeyn, M.E. Wickham, K.M. Davern, B.M. Cooke, R.L. Coppel, J.C. Reeder, J.G.
Culvenor, R.F. Waller, A.F. Cowman, Targeted mutagenesis of Plasmodium falciparum
erythrocyte membrane protein 3 (PfEMP3) disrupts cytoadherence of malaria-
infected red blood cells, EMBO J. 19 (2000) 2813–2823.
[41] K. Kuwasako, Y.N. Cao, C.P. Chu, S. Iwatsubo, T. Eto, K. Kitamura, Functions of the
cytoplasmic tails of the human receptor activity-modifying protein components of
calcitonin gene-related peptide and adrenomedullin receptors, J. Biol. Chem. 281
(2006) 7205–7213.
[42] S. Steiner, R. Muff, R. Gujer, J.A. Fischer, W. Born, The transmembrane domain of
receptor-activity-modifying protein 1 is essential for the functional expression of
a calcitonin gene-related peptide receptor, Biochemistry 41 (2002) 11398–11404.
1628 L.M. Kats et al. / Biochimica et Biophysica Acta 1848 (2015) 1619–1628[43] T. Sahar, K.S. Reddy, M. Bharadwaj, A.K. Pandey, S. Singh, C.E. Chitnis, D. Gaur,
Plasmodium falciparum reticulocyte binding-like homologue protein 2 (PfRH2) is a
key adhesivemolecule involved in erythrocyte invasion, PLoS ONE 6 (2011) e17102.
[44] L. Bannister, J. Hopkins, A. Dluzewski, G. Margos, I. Williams, M. Blackman, C.
Kocken, A. Thomas, G. Mitchell, Plasmodium falciparum apical membrane antigen
1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules
during merozoite development, J. Cell Sci. 116 (2003) 3825–3834.
[45] C. Collins, C. Withers-Martinez, F. Hackett, M. Blackman, An inhibitory antibody
blocks interactions between components of the malarial invasion machinery, PLoS
Pathog. 5 (2009) e1000273.
[46] M. Treeck, S. Zacherl, S. Herrmann, A. Cabrera, M. Kono, N.S. Struck, K. Engelberg, S.
Haase, F. Frischknecht, K. Miura, T. Spielmann, T.W. Gilberger, Functional analysisof the leading malaria vaccine candidate AMA-1 reveals an essential role for the
cytoplasmic domain in the invasion process, PLoS Pathog. 5 (2009) e1000322.
[47] E. Hanssen, P. Hawthorne, M.W. Dixon, K.R. Trenholme, P.J. McMillan, T. Spielmann,
D.L. Gardiner, L. Tilley, Targeted mutagenesis of the ring-exported protein-1 of
Plasmodium falciparum disrupts the architecture of Maurer's cleft organelles, Mol.
Microbiol. 69 (2008) 938–953.
[48] E. Pachlatko, S. Rusch, A. Muller, A. Hemphill, L. Tilley, E. Hanssen, H.P. Beck,
MAHRP2, an exported protein of Plasmodium falciparum, is an essential component
of Maurer's cleft tethers, Mol. Microbiol. 77 (2010) 1136–1152.
